June 27, 2023 — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president of the Society of Nuclear Medicine and
In a joint conference event on Monday, cell therapy pioneer Carl June revealed unpublished results showing that in around 1,500 patients treated with CAR-T therapies,…
PURPOSE Nodular lymphocyte–predominant Hodgkin lymphoma (NLPHL) is a rare cancer, and large international cooperative efforts are needed to evaluate the significance of clinical risk factors…
Background Loss of AZGP1 expression is a biomarker associated with progression to castration resistance, development of metastasis, and poor disease-specific survival in prostate cancer. However,…
Ferroptosis regulation remains poorly understood. Rodencal et al. demonstrate that cell cycle arrest enhances sensitivity to ferroptosis when ferroptosis is induced by direct inhibition of GPX4.…
A funding opportunity for individuals across the educational continuum to facilitate continued support in projects that make progress towards inclusive excellence at the Stanford Cancer…
The award provides generous funding for immigrants and children of immigrants pursuing graduate degrees.
npj Digital Medicine – Human-AI interaction in skin cancer diagnosis: a systematic review and meta-analysis
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer. Although cSCC contributes to substantial morbidity and mortality in high-risk individuals, deployment of…
Background:In situ vaccination for the treatment of cancer aims to trigger an immune response locally that propagates systemically. We have shown that local tre
CRISPR technologies have begun to revolutionize T cell therapies; however, conventional CRISPR-Cas9 genome-editing tools are limited in their safety, …
